An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation
Science Immunology · 2026
DOI: 10.1126/sciimmunol.aea0515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Mariko Aoki und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Pyrin, Inflammasomes, cdc42 GTP-Binding Protein, Familial Mediterranean Fever. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Japan Society for the Promotion of Science, Japan Science and Technology Agency.
Abstract (Originalsprache)
Heterozygous carboxyl-terminal variants in the RHO guanosine triphosphatase (GTPase) CDC42 are known to cause severe autoinflammatory syndromes. Here, we identified a heterozygous amino-terminal p.T43I (Thr 43 →Ile) CDC42 variant in patients with autoinflammation and uncovered a molecular link between CDC42 and the inflammasome sensor pyrin, mutated in the hereditary autoinflammatory syndrome familial Mediterranean fever. We demonstrate that the region surrounding residue T43 of CDC42 interacts with the carboxyl-terminal B30.2 domain of pyrin and regulates its localization and activation. The p.T43I substitution strengthens the CDC42-pyrin interaction through additional van der Waals interactions, leading to increased pyrin inflammasome activation, as evidenced by increased ASC (apoptosis-associated speck-like protein containing a caspase activating and recruitment domain) speck formation, enhanced pyroptosis, and excessive interleukin-1β (IL-1β) and IL-18 production. These findings identify CDC42 as a pyrin ligand and provide critical insights into the role of the pyrin B30.2 domain in inflammasome activation, suggesting dual regulation of pyrin by two RHO family GTPases, RHOA and CDC42.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Université Paris Cité, CNRS, Inserm, Institut Cochin, Paris, France.
- Sorbonne University, Department of Internal Medicine, Tenon Hospital, DMU3ID, Assistance Publique-Hôpitaux de Paris, Paris, France.
- French National Reference Center for Autoinflammatory Diseases (CEREMAIA), Paris, France.
- ERN RITA European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Disease Network, Utrecht, Netherlands.
- Pediatric Department, Versailles Hospital, Le Chesnay, France.
ORCID-Profile: Mariko Aoki, Alberto Iannuzzo, Philippe Mertz, Shouya Feng, Naoya Iwata, Chiara Perugini, Naomi Tsuchida, Rana El Masri, Yoshihiko Kuchitsu, Simona Coppola, Hirofumi Shibata, Masahiko Nishitani-Isa, Alexandre Terré, Yuri Kawasaki, Satoko Miyatake, Marc André, Keisuke Hamada, Jonathan London, Kazushi Izawa, Akira Niwa, Kazuhiro Ogata, Masashi Nishikawa, Marco Tartaglia, Shuichi Ito, Mathieu P Rodero, Koh-Ichi Nagata, Asma Smahi, Naomichi Matsumoto, Junko Takita, Guilaine Boursier, Atsushi Hijikata, Thomas Henry, Tomohiko Taguchi, Véronique Hentgen, Yoshitaka Honda, Seth L Masters, Takahiro Yasumi
Förderung
- Agence Nationale de la Recherche
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Istituto Superiore di Sanità
- Fondation pour la Recherche Médicale
- FUNDING
- Japanese Ministry of Health, Labor, and Welfare
- AMED
Zitieren
APA
Aoki, M., Iannuzzo, A., Mertz, P., Feng, S., Iwata, N., Perugini, C., Tsuchida, N., El Masri, R., Kuchitsu, Y., Tacine, R., Coppola, S., Shibata, H., Cescato, M., Nishitani-Isa, M., Terré, A., Kawasaki, Y., Dalmon, S., Nishimura, K., Magnotti, F., …, & Delon, J. (2026). An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation. Science Immunology. https://doi.org/10.1126/sciimmunol.aea0515
Vancouver
Aoki M, Iannuzzo A, Mertz P, Feng S, Iwata N, Perugini C, et al. An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation. Science Immunology. 2026. doi:10.1126/sciimmunol.aea0515
BibTeX
@article{Aoki2026,
author = {Aoki, Mariko and Iannuzzo, Alberto and Mertz, Philippe and Feng, Shouya and Iwata, Naoya and Perugini, Chiara and Tsuchida, Naomi and El Masri, Rana and Kuchitsu, Yoshihiko and Tacine, Rachida and Coppola, Simona and Shibata, Hirofumi and Cescato, Margaux and Nishitani-Isa, Masahiko and Terré, Alexandre and Kawasaki, Yuri and Dalmon, Sarah and Nishimura, Kenichi and Magnotti, Flora and Miyatake, Satoko and André, Marc and Hamada, Keisuke and London, Jonathan and Izawa, Kazushi and Niwa, Akira and Okamoto, Nobuhiko and Ogata, Kazuhiro and Nishikawa, Masashi and Zara, Erika and Saito, Megumu K and Tartaglia, Marco and Ito, Shuichi and Rodero, Mathieu P and Nagata, Koh-Ichi and Smahi, Asma and Matsumoto, Naomichi and Le Corre, Laurent and Takita, Junko and Boursier, Guilaine and Hijikata, Atsushi and Henry, Thomas and Taguchi, Tomohiko and Hentgen, Véronique and Georgin-Lavialle, Sophie and Honda, Yoshitaka and Masters, Seth L and Yasumi, Takahiro and Delon, Jérôme},
title = {An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation},
journal = {Science Immunology},
year = {2026},
doi = {10.1126/sciimmunol.aea0515}
}
EUVIMED